Diabetes Mellitus. Insulin-dependent diabetes mellitus
Conditions
Interventions
Intervention 1: Patients who are treated with new drugs, will received glargine insulin as basal insulin once day( before bedtime)and Sparta insulin as rapid effect of insulin with meals 3 times a day
Treatment - Drugs
Patients who are treated with new drugs, will received glargine insulin as basal insulin once day( before bedtime)and Sparta insulin as rapid effect of insulin with meals 3 times a day (breakfast, lun
NPH insulin-treated patients in the control group received twice a day ( before breakfast and dinner) with short-acting insulin regular three times daily( 30 minute before breakfast, lunch, dinner).
Sponsors
Tehran University of Medical Sciences Vice chancellor for research
Eligibility
Sex/Gender
All
Age
6 Years to 11 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: age between 6 to 11 years old; patient with diagnosis of type 1diabetes mellitus that under treatment of insulin at least 6 month; Body Mass Index below the 90th percentile at baseline and having the desire and ability to measure blood glucose self monitoring (SMBG) using glucometer devices. Exclusion criteria: diabetic patients with diabetes who have other mental and physical disorders; patients who did not complete the study period and patients with diabetes are not suitable for regular tracking and check.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| HbA1c. Timepoint: Every 3 month. Method of measurement: Labratory test.;Lipid profile. Timepoint: Every 6 month. Method of measurement: Laberatory test; mg/dl.;Fasting blood glucose. Timepoint: Everyday. Method of measurement: Laberatory test; mg/dl. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Aria Setoodeh
Tehran University of Medical Sciences
Outcome results
None listed